Daily Stocks News » CELG http://news.dailystocks.com Stocks with Insider Buying, Stock Search Engine, Glossary, Education, Reviews Mon, 21 Jan 2019 17:42:26 +0000 en hourly 1 http://wordpress.org/?v=3.3.2 Celgene Corporation Director Buys 1,000 Shares (CELG) http://news.dailystocks.com/3098/celgene-corporation-director-buys-1000-shares-celg/ http://news.dailystocks.com/3098/celgene-corporation-director-buys-1000-shares-celg/#comments Fri, 31 May 2013 18:12:57 +0000 Warren Paige http://news.dailystocks.com/?p=3098 Celgene Corporation (NASDAQ: CELG) director Ernest Mario bought 1,000 shares of CELG common stock for $123.72 per share, according to a SEC filing. Mario made a total investment of $123,725.

CELG shares have edged higher in trading today. At last check, the stock was trading 1.38% higher at $126.27 on volume of 1.78 million. [...]]]> http://news.dailystocks.com/3098/celgene-corporation-director-buys-1000-shares-celg/feed/ 0 Celgene Shares Gain after FDA Approval for POMALYST® (CELG) http://news.dailystocks.com/2372/celgene-shares-gain-after-fda-approval-for-pomalyst-celg/ http://news.dailystocks.com/2372/celgene-shares-gain-after-fda-approval-for-pomalyst-celg/#comments Mon, 11 Feb 2013 14:06:15 +0000 Warren Paige http://news.dailystocks.com/?p=2372 Shares of Celgene Corporation (NASDAQ: CELG), a global biopharmaceutical company engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases, have edged higher in pre-market trading today after the company’s POMALYST® was approved by the U.S. Food and Drug Administration (FDA).

POMALYST has been approved for treatment [...]]]> http://news.dailystocks.com/2372/celgene-shares-gain-after-fda-approval-for-pomalyst-celg/feed/ 0